GE Healthcare and Tribun Health combine digital pathology and imaging to optimize oncology diagnostics. To be discovered in SIH Solutions

In medicine, as in leadership, clarity, efficiency, and decision-making are key. Oncology is no exception. Yet, too often, critical clinical data is fragmented—genomics in one system, pathology in another, radiology elsewhere. This siloed approach serves no one, least of all the patient.

A recent article published in SIH Solutions highlights a major breakthrough: GE Healthcare and Tribun Health are joining forces to provide clinicians with a complete view, without delay or uncertainty.

A system designed for clinicians

Strong institutions are built on solid foundations, and in health, in 2025, that foundation is made up of accurate and accessible data. GE Healthcare’s VNA (Vendor Neutral Archive) and Tribun Health’s AI-powered CaloPix® platform bring together different imaging disciplines into a single, integrated system. As a result, clinicians can work more efficiently, quickly detect potential discrepancies, and make decisions with confidence.

Precision above all

Decisions in oncology must be based on hard evidence, not assumptions. Tribun Health’s CaloPix® platform, voted Best in KLAS three years in a row, supports pathologists and oncologists in making accurate and informed diagnoses. AI doesn’t replace human expertise, it amplifies it—reducing unnecessary delays and enabling faster, more reliable treatment planning.

A decisive step for oncology

Progress is not born of hesitation, but of action. This partnership between GE Healthcare and Tribun Health marks a breakthrough toward a more efficient and intelligent approach to oncology care—one where clinicians focus on their patients, not managing fragmented data.